167 related articles for article (PubMed ID: 38563820)
1. Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.
Horesh ME; Martin-Fernandez M; Gruber C; Buta S; Le Voyer T; Puzenat E; Lesmana H; Wu Y; Richardson A; Stein D; Hodeib S; Youssef M; Kurowski JA; Feuille E; Pedroza LA; Fuleihan RL; Haseley A; Hovnanian A; Quartier P; Rosain J; Davis G; Mullan D; Stewart O; Patel R; Lee AE; Rubinstein R; Ewald L; Maheshwari N; Rahming V; Chinn IK; Lupski JR; Orange JS; Sancho-Shimizu V; Casanova JL; Abul-Husn NS; Itan Y; Milner JD; Bustamante J; Bogunovic D
J Exp Med; 2024 Jun; 221(6):. PubMed ID: 38563820
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of JAK1-associated inflammatory disease.
Fayand A; Hentgen V; Posseme C; Lacout C; Picard C; Moguelet P; Cescato M; Sbeih N; Moreau TRJ; Zhu YYJ; Charuel JL; Corneau A; Deibener-Kaminsky J; Dupuy S; Fusaro M; Hoareau B; Hovnanian A; Langlois V; Le Corre L; Maciel TT; Miskinyte S; Miyara M; Moulinet T; Perret M; Schuhmacher MH; Rignault-Bricard R; Viel S; Vinit A; Soria A; Duffy D; Launay JM; Callebert J; Herbeuval JP; Rodero MP; Georgin-Lavialle S
J Allergy Clin Immunol; 2023 Oct; 152(4):972-983. PubMed ID: 37343845
[TBL] [Abstract][Full Text] [Related]
3. Correction: Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.
Horesh ME; Martin-Fernandez M; Gruber C; Buta S; Le Voyer T; Puzenat E; Lesmana H; Wu Y; Richardson A; Stein D; Hodeib S; Youssef M; Kurowski JA; Feuille E; Pedroza LA; Fuleihan RL; Haseley A; Hovnanian A; Quartier P; Rosain J; Davis G; Mullan D; Stewart O; Patel R; Lee AE; Rubinstein R; Ewald L; Maheshwari N; Rahming V; Chinn IK; Lupski JR; Orange JS; Sancho-Shimizu V; Casanova JL; Abul-Husn NS; Itan Y; Milner JD; Bustamante J; Bogunovic D
J Exp Med; 2024 Jun; 221(6):. PubMed ID: 38709237
[No Abstract] [Full Text] [Related]
4. JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.
Klaeschen AS; Nümm TJ; Herrmann N; Leib N; Maintz L; Sakai T; Wenzel J; Bieber T
J Allergy Clin Immunol; 2021 Jun; 147(6):2202-2212.e8. PubMed ID: 33338537
[TBL] [Abstract][Full Text] [Related]
5. Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation.
Biggs CM; Cordeiro-Santanach A; Prykhozhij SV; Deveau AP; Lin Y; Del Bel KL; Orben F; Ragotte RJ; Saferali A; Mostafavi S; Dinh L; Dai D; Weinacht KG; Dobbs K; Ott de Bruin L; Sharma M; Tsai K; Priatel JJ; Schreiber RA; Rozmus J; Hosking MC; Shopsowitz KE; McKinnon ML; Vercauteren S; Seear M; Notarangelo LD; Lynn FC; Berman JN; Turvey SE
JCI Insight; 2022 Dec; 7(24):. PubMed ID: 36546480
[TBL] [Abstract][Full Text] [Related]
6. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP; Cagdas D; Castelle M; Chan AY; Chandrakasan S; Chetty K; Cougoul P; Crickx E; Dara J; Deyà-Martínez A; Farmand S; Formankova R; Gennery AR; Gonzalez-Granado LI; Hagin D; Hanitsch LG; Hanzlikovà J; Hauck F; Ivorra-Cortés J; Kisand K; Kiykim A; Körholz J; Leahy TR; van Montfrans J; Nademi Z; Nelken B; Parikh S; Plado S; Ramakers J; Redlich A; Rieux-Laucat F; Rivière JG; Rodina Y; Júnior PR; Salou S; Schuetz C; Shcherbina A; Slatter MA; Touzot F; Unal E; Lankester AC; Burns S; Seppänen MRJ; Neth O; Albert MH; Ehl S; Neven B; Speckmann C
J Allergy Clin Immunol; 2024 Jan; 153(1):275-286.e18. PubMed ID: 37935260
[TBL] [Abstract][Full Text] [Related]
7. Sensory neurons promote immune homeostasis in the lung.
Tamari M; Del Bel KL; Ver Heul AM; Zamidar L; Orimo K; Hoshi M; Trier AM; Yano H; Yang TL; Biggs CM; Motomura K; Shibuya R; Yu CD; Xie Z; Iriki H; Wang Z; Auyeung K; Damle G; Demircioglu D; Gregory JK; Hasson D; Dai J; Chang RB; Morita H; Matsumoto K; Jain S; Van Dyken S; Milner JD; Bogunovic D; Hu H; Artis D; Turvey SE; Kim BS
Cell; 2024 Jan; 187(1):44-61.e17. PubMed ID: 38134932
[TBL] [Abstract][Full Text] [Related]
8. JAK1/JAK2 degraders based on PROTAC for topical treatment of atopic dermatitis.
Wu J; Li L; Zhu Q; Zhang T; Miao F; Cui Z; Dong G; Tai Z; Chen Z
Biomed Pharmacother; 2024 Feb; 171():116167. PubMed ID: 38262152
[TBL] [Abstract][Full Text] [Related]
9. IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1/microRNA-155 axis.
Chang J; Zhou B; Wei Z; Luo Y
J Transl Med; 2022 May; 20(1):207. PubMed ID: 35545774
[TBL] [Abstract][Full Text] [Related]
10. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
11. Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib.
Ferreira S; Guttman-Yassky E; Torres T
Am J Clin Dermatol; 2020 Dec; 21(6):783-798. PubMed ID: 32776305
[TBL] [Abstract][Full Text] [Related]
12. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
Nakashima C; Yanagihara S; Otsuka A
Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
[TBL] [Abstract][Full Text] [Related]
13. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
[TBL] [Abstract][Full Text] [Related]
14. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
Front Immunol; 2020; 11():344. PubMed ID: 32194562
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.
Fridman JS; Scherle PA; Collins R; Burn T; Neilan CL; Hertel D; Contel N; Haley P; Thomas B; Shi J; Collier P; Rodgers JD; Shepard S; Metcalf B; Hollis G; Newton RC; Yeleswaram S; Friedman SM; Vaddi K
J Invest Dermatol; 2011 Sep; 131(9):1838-44. PubMed ID: 21677670
[TBL] [Abstract][Full Text] [Related]
16. English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
Saeki H; Akiyama M; Abe M; Igarashi A; Imafuku S; Ohya Y; Katoh N; Kameda H; Kabashima K; Tsunemi Y; Hide M; Ohtsuki M;
J Dermatol; 2023 Jan; 50(1):e1-e19. PubMed ID: 36412059
[TBL] [Abstract][Full Text] [Related]
17. Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice.
Jin W; Huang W; Chen L; Jin M; Wang Q; Gao Z; Jin Z
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544712
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.
Hornakova T; Staerk J; Royer Y; Flex E; Tartaglia M; Constantinescu SN; Knoops L; Renauld JC
J Biol Chem; 2009 Mar; 284(11):6773-81. PubMed ID: 19139102
[TBL] [Abstract][Full Text] [Related]
19. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.
Zhang Y; Yu X; Ichikawa M; Lyons JJ; Datta S; Lamborn IT; Jing H; Kim ES; Biancalana M; Wolfe LA; DiMaggio T; Matthews HF; Kranick SM; Stone KD; Holland SM; Reich DS; Hughes JD; Mehmet H; McElwee J; Freeman AF; Freeze HH; Su HC; Milner JD
J Allergy Clin Immunol; 2014 May; 133(5):1400-9, 1409.e1-5. PubMed ID: 24589341
[TBL] [Abstract][Full Text] [Related]
20. ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon.
Hornakova T; Chiaretti S; Lemaire MM; Foà R; Ben Abdelali R; Asnafi V; Tartaglia M; Renauld JC; Knoops L
Blood; 2010 Apr; 115(16):3287-95. PubMed ID: 20167706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
